NAUT
NAUT
NASDAQ · Life Sciences Tools & Services

Nautilus Biotechnology Inc

$3.48
-0.30 (-7.94%)
As of Mar 29, 10:32 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +663.2% upside
Low Target $24.26
Average Target $26.56
High Target $41.87
Current Price $3.48
Current
$3.48
Target
$26.56
$24.26 $26.56 avg $41.87
Scenario Analysis
Bear Case
$24.26
597.1%
Low target
Base Case
$26.56
+663.2%
Avg target
Bull Case
$41.87
+1,103.2%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$3.08
13.0% from high
52-Week Low
$0.62
+461.3% from low
Target vs 52W High
$26.56
+762.3% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 33 88% $369.21 -25.3%
DHR
Danaher Corp
Strong Buy 30 87% $158.11 -17.1%
A
Agilent Technologies Inc
Buy 29 72% $64.69 -43.5%
IQV
Iqvia Holdings Inc
Strong Buy 30 80% $82.96 -51.9%
MTD
Mettler-Toledo International
Hold 21 43% $170.43 -86.6%
ILMN
Illumina Inc
Hold 28 54% $169.36 +33.7%
WAT
Waters Corp
Buy 28 57% $189.60 -36.8%
WST
West Pharmaceutical Services
Strong Buy 23 78% $136.24 -46.1%